Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Nosocomial Infections


BASICS


DESCRIPTION


  • Health care " “associated infections (HAIs)
  • Infection must not have been present or incubating on admission to a health care facility.
  • CDC categories:
    • Catheter-associated urinary tract infection (CAUTI)
    • Surgical site infection (SSI)
    • Ventilator-associated pneumonia (VAP)
    • Central line " “associated bloodstream infection (CLABSI)
    • Clostridium difficile infection (C. diff, C. difficile, CDAD, CDI)
  • The National Healthcare Safety Network (NHSN) at www.cdc.gov/nhsn monitors emerging HAI pathogens and their mechanisms of resistance to promote current prevention strategies.
  • Medicare and Medicaid will not pay for the treatment of certain HAI including CAUTIs, CLABSIs, and SSIs.

EPIDEMIOLOGY


  • General
    • 13/1,000 patient-days in the ICU (1)
    • 7/1,000 patient-days in high-risk nurseries
    • 2.6/1,000 patient-days in nurseries (1)
    • Estimated cost of HAIs is $20 billion per year (2).
  • Infection specific
    • CAUTI
      • Hospital stay increased by 1 to 3 days.
      • Cost up to $600/infection
    • VAP
      • Hospital stay increased by 6 days.
      • Cost up to $5,000/infection
    • CLABSI
      • Hospital stay increased by 7 to 20 days.
      • Cost up to $56,000/infection
    • SSI
      • Hospital stay increased by 7.3 days.
      • Cost >$3,000/infection
      • May not be apparent until 1 month after surgery
    • C. difficile infection (see topic "Clostridium difficile Infection " ¯)

Incidence
  • 1 out of 25 inpatients in the United States has at least one HAI (3).
    • 722,000 HAIs in U.S. acute care hospitals in 2011 (3)
    • UTI: 13% of HAIs (3)
    • Pneumonia: 22% of HAIs (3)
    • Bloodstream infection: 10% of HAIs (3)
    • SSI: 22% of HAIs (3)
    • 107,000 C. difficile cases in 2011(4)[A]
  • Infections caused by gram-negative rods resistant to almost all antibiotics are increasing. Up to 70% of nosocomial infections are resistant to at least one previously active antimicrobial.

ETIOLOGY AND PATHOPHYSIOLOGY


  • Endogenous spread: Patient host flora causes invasive disease (most common).
  • Exogenous spread: Flora acquired from within health care facility.
  • Causative organisms
    • UTI: Escherichia coli, Klebsiella spp., Serratia spp., Enterobacter, Pseudomonas aeruginosa, Enterococcus spp., Candida albicans (3)
    • Pneumonia: aerobic gram-negative bacilli, Staphylococcus aureus, P. aeruginosa, Streptococcus spp. (3)
    • Bloodstream infection: Staphylococcus spp., Candida spp., Enterococcus spp., gram-negative bacilli (3)
    • SSI: S. aureus, gram-negative bacilli, Enterococcus spp., Streptococcus spp., Enterobacter spp., Bacteroides spp. (3)

RISK FACTORS


  • Extremes of age
  • Invasive surgical procedures (abdominal surgeries, orthopedic surgeries, urogynecologic surgeries, neurosurgery)
  • Use of indwelling medical devices.
  • Chronic disease (including diabetes, renal failure, and malignancy)
  • Immunodeficiency
  • Malnutrition
  • Medications (recent antibiotics, proton pump inhibitors, and sedatives)
  • Colonization with pathogenic strains of flora
  • Breakdown of mucosal/cutaneous barriers, including trauma and battle wounds
  • Anesthesia
  • Lack of attention to detail with universal precautions

GENERAL PREVENTION


  • Prevention should target both patient-specific and facility-related risk factors.
  • Hand hygiene " ”thoroughly wash hands (5)[C]
    • On entering and leaving any patient room (5)
    • After contact with blood, excretions, body fluids, wound dressings, nonintact skin, mucous membranes (5)
    • Before using and after removing gloves (gloves are permeable to bacteria)
    • When moving hands from contaminated to clean body site (5)
    • Alcohol-based products are satisfactory when hands are not visibly soiled (5).
    • Soap and water should be used when surfaces are visibly soiled or when contact with spores is anticipated.
  • Antibiotic stewardship " ”appropriate selection of antimicrobial therapy includes the following:
    • Judicious use of antibiotics to reduce the emergence of multidrug-resistant organisms and the occurrence of C. difficile infection (2).
    • Use of narrow-spectrum early-generation antibiotics when possible.
    • Taking an antibiotic "time out " ¯ at 72 hours to review the patient 's clinical status and culture results, and eliminate ( "streamline " ¯) any redundant or unnecessary antibiotics
    • Use shorter courses of antibiotics when appropriate.
  • Hospital-based surveillance programs and antibiograms
  • Infection control programs with specially trained employees (5)[C]
  • Employee education on HAIs (5)[C]
  • Disinfection of hospital rooms with hydrogen peroxide vapor or UV irradiation in addition to standard cleaning reduces environmental contamination and the risk of infection with multidrug-resistant organisms.
  • Minimize invasive procedures.
  • Caregiver stethoscope cleaning
    • Stethoscope bacterial contamination is common. Regular cleaning with alcohol-based preparations reduces bacterial load. Evidence is lacking to confirm whether stethoscope contamination causes nosocomial infections.
  • Isolation of known pathogen carriers (5)[A]
    • Contact precautions
      • Institute for known pathogens spread by direct contact including methicillin-resistant S. aureus (MRSA), vancomycin-resistant Enterococcus (VRE), C. difficile, extended-spectrum ˇ ²-lactamase " “producing gram-negative rods, and carbapenemase-producing gram-negative rods.
      • Glove when entering room (5)[B]
      • Gown if clothing will touch patient or environment (5)[B]
    • Droplet precautions
      • Infectious particles measure >5 ˇ ¼m.
      • Institute for pathogens shed via talking, coughing, sneezing, mucosal shedding, airway suctioning, and bronchoscopy. These include Neisseria meningitidis, influenza, Haemophilus influenzae, Corynebacterium diphtheriae, and Bordetella pertussis.
      • Mask when entering room (5)[B]
    • Airborne precautions
      • Infectious particles measure <5 ˇ ¼m.
      • Institute for pathogens shed via coughing including tuberculosis, varicella-zoster virus, and measles.
      • Fit-tested National Institute of Occupational Safety and Health (NIOSH) " “approved ≥ N-95 respirator on entering room (5)[B]
  • Infection-specific measures
    • CAUTI
      • Employee education on urinary catheters (indications, placement, maintenance)
      • Sterile catheter placement technique (6)[C]
      • Closed urine collection system (6)[C]
      • Use catheter only for necessary duration and remove as early as possible (6)[B].
      • Use of nurse-driven protocols for guideline-driven catheter removal.
      • Do not confuse catheter-associated asymptomatic bacteriuria with CAUTI.
      • Do not screen for bacteriuria by routinely performing a urine culture when the catheter is withdrawn.
    • VAP
      • Intubate only when clinically necessary (7)[C]
      • Perform oral decontamination with oral chlorhexidine (8)[A].
      • Avoid nasotracheal intubation (7)[B].
      • Inline suctioning (7)[C]
      • Elevate head to 30 to 45 degrees (7)[C].
    • CLABSI
      • Educate staff about appropriate use of IV catheters (indications, placement, maintenance) (9)[A].
      • Place catheters using sterile technique (including chlorhexidine prep and maximal barrier precautions) (9)[A].
      • Use order "bundles " ¯ to improve adherence to catheter insertion guidelines.
      • Remove catheter promptly when no longer clinically indicated (9)[A].
      • Hand hygiene in addition to glove use (9)[A]
      • Regularly monitor catheter site (9)[A].
      • With introduction of these measures, CLASBI rates fell 46% between 2008 and 2011 (10)[A].
    • SSI
      • Proper surgical hand hygiene (2)[B]
      • Prophylactic antibiotic therapy when indicated (2)[A]; eliminate underlying infections before surgery if possible (2)[A].
      • Remove hair with electric clippers/depilatory agent prior to incision (2)[B].
      • Poor postoperative blood sugar control increases risk of infection.
    • C. difficile infection
      • Gloves combined with hand hygiene with soap and water (spores are resistant to alcohol-based products) (2)
      • Restrict use of fluoroquinolones, cephalosporins, and clindamycin when possible (2).
      • C. difficile is associated with the use of proton pump inhibitors: H2 blockers is preferred for acid suppression (11)[A].
      • Probiotics may reduce nonspecific antibiotic-associated diarrhea; the effectiveness of probiotics for prevention of C. difficile is unclear (11).
    • Bloodstream infections
      • Use of chlorhexidine-impregnated washcloths to bathe ICU patients reduces bloodstream infections by 28% (12)[B].
      • Routine surveillance for systemic inflammatory response syndrome (SIRS) using established criteria

DIAGNOSIS


Consistent with nature of infection ‚  

HISTORY


  • Exposure to health care facility
  • Recent surgery/open wounds
  • History of invasive procedure
    • Urinary catheter placement
    • Indwelling vascular catheter
  • Recent intubation/mechanical ventilation
  • History of past infections (MRSA, VRE, etc.)

PHYSICAL EXAM


Consistent with nature of infection; site-specific exam for infections of skin, catheter sites, wounds, signs of sepsis, or pneumonia ‚  

DIFFERENTIAL DIAGNOSIS


  • Community-acquired infection
  • Sepsis/SIRS
  • Other causes of infectious diarrhea

DIAGNOSTIC TESTS & INTERPRETATION


Specific to condition ‚  
  • CBC, blood culture
  • Wound culture
  • Urine culture
  • Chest x-ray
  • Stool culture

Test Interpretation
Consistent with underlying infection ‚  

TREATMENT


GENERAL MEASURES


  • Treat with appropriate antibiotics.
  • Order bundles improve adherence to sepsis guidelines and improves survival.
  • UTI: Remove urinary catheters.
  • CLABSI: Remove IV catheter.
  • C. difficile: Stop all antibiotics not being used to treat C. difficile infection.

MEDICATION


First Line
  • Targeted antimicrobial therapy
  • Several agents have been recently approved for the treatment of antibiotic-resistant infections and should be considered for second-line therapy.
    • Daptomycin, telavancin, dalbavancin, ceftaroline, oritavancin, tedizolid, ceftolozane-tazobactam, and ceftazidime-avibactam

ISSUES FOR REFERRAL


  • Failure to respond to initial therapy
  • Some emerging resistant gram-negative infections are resistant to nearly all antibiotics and require expert consultation for management.

SURGERY/OTHER PROCEDURES


  • Screening for nasal carriage and isolation reduce the nosocomial spread of MRSA.
  • Treating proven nasal carriers of Staphylococcus or MRSA with mupirocin prevents S. aureus nosocomial infections after surgery, as long as the prevalence of mupirocin resistance is low (13)[B].

INPATIENT CONSIDERATIONS


IV Fluids
As needed for hemodynamic support ‚  
Nursing
  • Hand washing should be performed on entering and exiting the patient room even when there is no direct contact with the patient.
  • Isolation precautions as indicated

Discharge Criteria
When infection has resolved or patient is stable and not an infectious risk ‚  

ONGOING CARE


FOLLOW-UP RECOMMENDATIONS


Patient Monitoring
Risk for recurrence is generally low in immunocompetent patients. Manage underlying comorbidities (risk factors). ‚  

PROGNOSIS


  • 99,000 deaths in 2002 in the United States (1)
  • Bloodstream infection mortality: 27%
  • Pneumonia mortality: 33 " “50%
  • SSI mortality: 11%

COMPLICATIONS


Related to specific nature of infection ‚  

REFERENCES


11 Klevens ‚  RM, Edwards ‚  JR, Richards ‚  CLJr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep.  2007;122(2):160 " “166.22 Yokoe ‚  DS, Mermel ‚  LA, Anderson ‚  DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol.  2008;29(Suppl 1):S12 " “S21.33 Magill ‚  SS, Edwards ‚  JR, Bamberg ‚  W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med.  2014;370(13):1198 " “1208.44 Lessa ‚  FC, Mu ‚  Y, Bamberg ‚  WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med.  2015;372(9):825 " “834.55 Siegel ‚  JD, Rhinehart ‚  E, Jackson ‚  M, et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control.  2007;35(10)(Suppl 2):S65 " “S164.66 Hooton ‚  TM, Bradley ‚  SF, Cardenas ‚  DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis.  2010;50(5):625 " “663.77 Tablan ‚  OC, Anderson ‚  LJ, Besser ‚  R, et al. Guidelines for preventing health-care associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep.  2004;53(RR-3):1 " “36.88 Chan ‚  EY, Ruest ‚  A, Meade ‚  MO, et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ.  2007;334(7599):889.99 O ' Grady ‚  NP, Alexander ‚  M, Burns ‚  LA, et al. 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections. www.cdc.gov/hicpac/BSI/01-BSI-guidelines-2011.html. Accessed 2011.1010 Centers for Disease Control and Prevention. 2013 National and State Healthcare-Associated Infections Progress Report. www.cdc.gov/hai/progress-report/index.html.1111 Surawicz ‚  CM, Brandt ‚  LJ, Binion ‚  DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol.  2013;108(4):478 " “498.1212 Climo ‚  MW, Yokoe ‚  DS, Warren ‚  DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med.  2013;368(6):533 " “542.1313 van Rijen ‚  M, Bonten ‚  M, Wenzel ‚  R, et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev.  2008;(4):CD006216.

CODES


ICD10


  • T83.51XA Infect/inflm reaction due to indwell urinary catheter, init
  • T81.4XXA Infection following a procedure, initial encounter
  • J95.851 Ventilator associated pneumonia
  • T82.7XXA Infect/inflm react d/t oth cardi/vasc dev/implnt/grft, init
  • N39.0 Urinary tract infection, site not specified

ICD9


  • 996.64 Infection and inflammatory reaction due to indwelling urinary catheter
  • 998.59 Other postoperative infection
  • 997.31 Ventilator associated pneumonia
  • 999.31 Other and unspecified infection due to central venous catheter
  • 599.0 Urinary tract infection, site not specified

SNOMED


  • 19168005 Nosocomial infectious disease (disorder)
  • 371061003 infection of bladder catheter (disorder)
  • 33910007 Postoperative infection (disorder)
  • 425464007 Nosocomial pneumonia (disorder)
  • 68566005 urinary tract infectious disease (disorder)
  • 431193003 Infection of bloodstream (disorder)

CLINICAL PEARLS


  • Nosocomial infections increase mortality, length of hospital stay, and cost of hospitalization.
  • Preventive efforts should address patient-specific and facility-related risk factors.
  • Proper hand hygiene, using an alcohol-based hand product or soap and water should be carried out before and after each patient encounter, even when gloves are used. Alcohol-based hand rubs are not effective for killing spores formed by C. difficile. Hand washing with soap and water is preferred in this situation.
  • Adherence to contact, droplet, or airborne precautions reduces the spread of infection.
  • The risk of developing a resistant nosocomial infection can be reduced by antibiotic streamlining, use of narrow-spectrum antibiotics, and frequent patient reevaluation to ensure the necessity of continuing antibiotics.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer